DTx Pharma was acquired by Novartis in July of 2023. This page is no longer active. Thank you to our followers and please follow Novartis for future updates.
View Top Employees from DTx Pharma| Website | http://www.novartis.com |
| Revenue | $5.1 million |
| Employees | 49 (49 on RocketReach) |
| Founded | 2017 |
| Address | 3210 Merryfield Row, San Diego, California 92121, US |
| Technologies |
JavaScript,
HTML,
PHP
+20 more
(view full list)
|
| Industry | Biotechnology, Pharmaceuticals, Healthcare, Science and Engineering, Drug Delivery, Therapeutics, Health Care |
| Competitors | Biotech Primer, Inception Therapeutics, Revitope |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 325 Companies, NAICS Code 54 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular DTx Pharma employee's phone or email?
DTx Pharma Questions
The DTx Pharma annual revenue was $5.1 million in 2024.
Bryan Laffitte is the Chief Scientific Officer of DTx Pharma.
49 people are employed at DTx Pharma.
DTx Pharma is based in San Diego, California.
The NAICS codes for DTx Pharma are [541, 325, 54, 3254, 32, 32541].
The SIC codes for DTx Pharma are [28, 283].
Top DTx Pharma Employees
-
25+
-
44
-
14
-
35+
-
45+
-
ViewStephanie Kareht
Sr. Director, Head of Medical Writing at DTx Pharma
San Francisco, California, United States44 -
11
-
41
-
14
Related Companies
